Osimertinib for Treating Non Small Cell Cancer

FDA approved osimertinib tablets to use as a first-line treatment for patients with non-small cell lung cancer (NSCLC) that has spread to other body parts and where the tumor has specific gene mutations confirmed by an FDA-approved test.

from Medindia Latest Updates https://ift.tt/2Q6UWwF